Surrogate markers for atherosclerosis in overweight subjects with atherogenic dyslipidemia: The GEMS project

Angiology

Volumn 59, Issue 4, 2008, Pages 484-492

  Genoud, Myriam ^a   Wietlisbach, Vincent ^a   Feihl, François ^a   Mermod, Alice ^a   Morin, Diane ^c   Darioli, Roger ^a   Nicod, Pascal ^a   Mooser, Vincent ^b   Waeber, Bernard ^a   Hayoz, Daniel ^a   Waeber, Gérard ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b GLAXOSMITHKLINE   (United States)

^c BH 10 628 ^*

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTERIAL WALL THICKNESS; ARTERY ENDOTHELIUM; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CAROTID ARTERY; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DYSLIPIDEMIA; FEMALE; FEMORAL ARTERY; GENDER; HUMAN; LASER DOPPLER FLOWMETRY; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; OBESITY; SKIN BLOOD VESSEL; STATISTICAL SIGNIFICANCE; TEMPERATURE SENSITIVITY; VASODILATATION;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD PRESSURE; CAROTID ARTERIES; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; DYSLIPIDEMIAS; ENDOTHELIUM, VASCULAR; FEMALE; FEMORAL ARTERY; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; OVERWEIGHT; RISK ASSESSMENT; RISK FACTORS; SKIN; TRIGLYCERIDES; VASODILATION;

EID: 49649114340     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319707307768     Document Type: Article

References (28)

1. Ford ES, Giles WH, Dietz WH Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002 ; 287 (3). 356-359.
2. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001 ; 285 (19). 2486-2497.
3. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003 ; 107 (3). 391-397.
4. Grundy SM Inflammation, hypertension, and the metabolic syndrome. JAMA. 2003 ; 290 (22). 3000-3002.
5. Giral P., Pithois-Merli I., Filitti V., et al. Risk factors and early extracoronary atherosclerotic plaques detected by 3-site ultrasound imaging in hypercholesterolemic men. Prevention Cardio-vasculaire en Medecine du Travail METRA Group. Arch Intern Med. 1991 ; 151 (5). 950-956.
6. Paivansalo M., Rantala A., Kauma H., et al. Prevalence of carotid atherosclerosis in middle-aged hypertensive and control subjects. A cross-sectional systematic study with duplex ultrasound. J Hypertens. 1996 ; 14 (12). 1433-1439.
7. Badimon JJ, Fuster V., Chesebro JH, Badimon L. Coronary atherosclerosis. A multifactorial disease. Circulation. 1993 ; 87 (3 Suppl). 113-1116.
8. Solberg LA, Strong JP Risk factors and atherosclerotic lesions. A review of autopsy studies. Arteriosclerosis. 1983 ; 3 (3). 187-198.
9. de Groot E., Hovingh GK, Wiegman A., et al. Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation. 2004 ; 109 (23 Suppl 1). I1133 - I1138.
10. Zureik M., Ducimetiere P., Touboul PJ, et al. Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: longitudinal results from the Aging Vascular Study (EVA) study. Arterioscler Thromb Vasc Biol. 2000 ; 20 (6). 1622-1629.
11. Davignon J., Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004 ; 109 (23 Suppl 1). I1127 - I1132.
12. Mancini GB, Henry GC, Macaya C., et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation. 1996 ; 94 (3). 258-265.
13. Kubli S., Waeber B., Dalle-Ave A., Feihl F. Reproducibility of laser Doppler imaging of skin blood flow as a tool to assess endothelial function. J Cardiovasc Pharmacol. 2000 ; 36 (5). 640-648.
14. Ridker PM, Rifai N., Rose L., Buring JE, Cook NR Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002 ; 347 (20). 1557-1565.
15. Rifai N., Ridker PM Inflammatory markers and coronary heart disease. Curr Opin Lipidol. 2002 ; 13 (4). 383-389.
16. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001 ; 285 (19). 2481-2485.
17. Wyszynski DF, Waterworth DM, Barter PJ, et al. Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project). Am J Cardiol. 2005 ; 95 (2). 194-198.
18. Danesh J., Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004 ; 350 (14). 1387-1397.
19. Bots ML, Hoes AW, Koudstaal PJ, Hofman A., Grobbee DE Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation. 1997 ; 96 (5). 1432-1437.
20. Hollander M., Bots ML, Del Sol AI, et al. Carotid plaques increase the risk of stroke and subtypes of cerebral infarction in asymptomatic elderly: the Rotterdam study. Circulation. 2002 ; 105 (24). 2872-2877.
21. Chambless LE, Heiss G., Folsom AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol. 1997 ; 146 (6). 483-494.
22. Li R., Duncan BB, Metcalf PA, et al. B-mode-detected carotid artery plaque in a general population. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Stroke. 1994 ; 25 (12). 2377-2383.
23. Heiss G., Sharrett AR, Barnes R., Chambless LE, Szklo M., Alzola C. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol. 1991 ; 134 (3). 250-256.
24. Seywert AJ, Kubli S., Giusti V., Feihl F., Waeber B., Tappy L. Similarity of cutaneous reactive hyperemia in the forearm of women with and without hyperinsulinemia. Int J Obes Relat Metab Disord. 2004 ; 28 (4). 611-615.
25. Bisoendial RJ, Hovingh GK, Levels JH, et al. Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein. Circulation. 2003 ; 107 (23). 2944-2948.
26. Assmann G., Gotto AM Jr. HDL cholesterol and protective factors in atherosclerosis. Circulation. 2004 ; 109 (23 Suppl 1). I118 - I1114.
27. Nofer JR, Kehrel B., Fobker M., Levkau B., Assmann G., von Eckardstein A. HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis. 2002 ; 161 (1). 1-16.
28. von Eckardstein A., Assmann G. Prevention of coronary heart disease by raising high-density lipoprotein cholesterol ? Curr Opin Lipidol. 2000 ; 11 (6). 627-637.